Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chandrashekhar K Ponde

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
World Journal of Cardiology|February 7, 2022
Fondaparinux: A cornerstone drug in acute coronary syndromesMohammed Yunus Khan, Chandrashekhar K Ponde, Viveka Kumar, et al.
Clinics in Laboratory Medicine|June 26, 2012
Cardiovascular disease in IndiaTester F Ashavaid, Chandrashekhar K Ponde, Swarup Shah, et al.
Molecular Biology Reports|November 25, 2018
Differential methylation pattern in patients with coronary artery disease: pilot studyShyamashree Banerjee, Chandrashekhar K Ponde, Rajesh M Rajani, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|April 22, 2016
Association of CYBA G640A variation with coronary artery disease in IndiansSripriya Natarajan, Chandrashekhar K Ponde, Rajesh M Rajani, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 14, 2012
Role of thrombomodulin gene in Indian population with coronary artery diseaseSwarup A Shah, Tester F Ashavaid, Ranjit Mankeshwar, et al.
Molecular Biology Reports|January 22, 2024
Does epigenetic markers of HLA gene show association with coronary artery disease in Indian subjects?Shyamashree Banerjee, Minal U Paradkar, Chandrashekhar K Ponde, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|July 20, 2018
Circulating miRNA-33: a potential biomarker in patients with coronary artery diseaseLakshmi Lavanya Reddy, Swarup A V Shah, Chandrashekhar K Ponde, et al.
Indian Journal of Clinical Biochemistry : IJCB|February 9, 2016
Troponin T and Heart Type Fatty Acid Binding Protein (h-Fabp) as Biomarkers in Patients Presenting with Chest PainLakshmi Lavanya Reddy, Swarup A V Shah, Alpa J Dherai, et al.
Journal of Cardiac Failure|July 18, 2025
An Indian Expert Consensus on Patient-Profile-Based Implementation of Guideline-Directed Medical Therapy in the Management of Heart Failure With Reduced Ejection Fraction: APPROACH-HFChandrashekhar K Ponde, Jagdish C Mohan, Abraham Oomman, et al.
Pharmacological Reports : PR|January 9, 2014
Effect of CYP2C9 and VKORC1 genetic variations on warfarin dose requirements in Indian patientsSripriya Natarajan, Chandrashekhar K Ponde, Rajesh M Rajani, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
World Journal of Cardiology|February 7, 2022
Fondaparinux: A cornerstone drug in acute coronary syndromesMohammed Yunus Khan, Chandrashekhar K Ponde, Viveka Kumar, et al.
Clinics in Laboratory Medicine|June 26, 2012
Cardiovascular disease in IndiaTester F Ashavaid, Chandrashekhar K Ponde, Swarup Shah, et al.
Molecular Biology Reports|November 25, 2018
Differential methylation pattern in patients with coronary artery disease: pilot studyShyamashree Banerjee, Chandrashekhar K Ponde, Rajesh M Rajani, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|April 22, 2016
Association of CYBA G640A variation with coronary artery disease in IndiansSripriya Natarajan, Chandrashekhar K Ponde, Rajesh M Rajani, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 14, 2012
Role of thrombomodulin gene in Indian population with coronary artery diseaseSwarup A Shah, Tester F Ashavaid, Ranjit Mankeshwar, et al.
Molecular Biology Reports|January 22, 2024
Does epigenetic markers of HLA gene show association with coronary artery disease in Indian subjects?Shyamashree Banerjee, Minal U Paradkar, Chandrashekhar K Ponde, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|July 20, 2018
Circulating miRNA-33: a potential biomarker in patients with coronary artery diseaseLakshmi Lavanya Reddy, Swarup A V Shah, Chandrashekhar K Ponde, et al.
Indian Journal of Clinical Biochemistry : IJCB|February 9, 2016
Troponin T and Heart Type Fatty Acid Binding Protein (h-Fabp) as Biomarkers in Patients Presenting with Chest PainLakshmi Lavanya Reddy, Swarup A V Shah, Alpa J Dherai, et al.
Journal of Cardiac Failure|July 18, 2025
An Indian Expert Consensus on Patient-Profile-Based Implementation of Guideline-Directed Medical Therapy in the Management of Heart Failure With Reduced Ejection Fraction: APPROACH-HFChandrashekhar K Ponde, Jagdish C Mohan, Abraham Oomman, et al.
Pharmacological Reports : PR|January 9, 2014
Effect of CYP2C9 and VKORC1 genetic variations on warfarin dose requirements in Indian patientsSripriya Natarajan, Chandrashekhar K Ponde, Rajesh M Rajani, et al.
Pageof 3